CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers
Open Access
- 3 July 2001
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 85 (1) , 36-40
- https://doi.org/10.1054/bjoc.2001.1777
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancerCarcinogenesis: Integrative Cancer Research, 1999
- Elevated Serum Estradiol and Testosterone Concentrations Are Associated with a High Risk for Breast CancerAnnals of Internal Medicine, 1999
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parametersEuropean Journal Of Cancer, 1996
- Unusual case of Smith‐Lemli‐Opitz syndrome “type II”American Journal of Medical Genetics, 1995
- Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factorsThe Journal of Pathology, 1993
- Trinucleotide (GGN) repeat polymorphism in the human androgen receptor (AR) geneHuman Molecular Genetics, 1993
- Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groupsGenomics, 1992
- RELATION BETWEEN URINARY ANDROGEN AND CORTICOID EXCRETION AND SUBSEQUENT BREAST CANCERThe Lancet, 1971